Back

Validation of the impact of post discharge change in hemoglobin by renal function on the prognosis of HFpEF patients after acute decompensated heart failure from the PURSUIT-HFpEF registry

28 August 2023 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Experimental heart failure Experimental Heart Failure ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Tetsuo Furukawa

Ikeda City Hospital, ikeda (Japan)

5 More presentations in this session

Presentation thumbnail
AAV.Cas9 and AAV.SERCA2a strategies to mitigate heart failure in DMD pigs
Doctor A. Baehr (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Acyl ghrelin increases cardiac output and preserves right ventricular-pulmonary arterial coupling in patients with heart failure
Mr M. Erhardsson (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
PDE2 is cardioprotective in chronic heart failure
Mr M. Groener (Dresden, DE)
Abstract Slides Video
Presentation thumbnail
Treatment of cardiomyocytes isolated from left ventricular myocardium of dogs with chronic heart failure with ALDA-1, an activator of aldehyde dehydrogenase-2, improves mitochondrial function
Professor H. Sabbah (Detroit, US)
Abstract Slides Video
Presentation thumbnail
Tristetraprolin in cardiomyocytes has a protective role in pressure-overloaded hearts
Doctor S. Omiya (Suita, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Experimental heart failure

The Event

Event poster

ESC Congress 2023

28 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Validation of the impact of post discharge change in hemoglobin on the prognosis of HFpEF patients after acute decompensated heart failure from PURSUIT-HFpEF registry
thumbnail
Congress Presentation
Prognostic impact of cardio-renal-anemia syndrome in heart failure - a report from the JROADHF database.
thumbnail
Congress Presentation
Unveiling the prognostic journey: renal function trajectories in 'de novo' heart failure with reduced ejection fraction - insights from a cohort study and their impact on patient outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources